Bimekizumab Continuous Maintenance of Eesponse at Every Visit Through Two Years in Patients with Moderate to Severe Plaque Psoriasis: Post-hoc Results from Five Phase 3/3b Trials
作者
Andrew Blauvelt,Curdin Conrad,Antonio Costanzo,Peter van de Kerkhof,George Han,Richard G B Langley,Leah Davis,Bengt Hoepken,Susanne Wiegratz,L. Puig
出处
期刊:Skin [National Society for Cutaneous Medicine] 日期:2024-01-16卷期号:8 (1): s303-s303